ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-22G14411
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Attention Deficit Hyperactivity Disorder ADHD Treatment Market Research Report 2023
BUY CHAPTERS

Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Research Report 2025

Code: QYRE-Auto-22G14411
Report
June 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Takeda
Johnson & Johnson
Eli Lilly
Tris Pharma
NEOS Therapeutics
Mallinckrodt plc
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
Zhengdafenhai
Highland Therapeutics
Jubilant Life Sciences
Medice Arzneimittel Putter
Lannett

Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size

The global market for Attention Deficit Hyperactivity Disorder (ADHD) Treatment was valued at US$ 13245 million in the year 2024 and is projected to reach a revised size of US$ 18640 million by 2031, growing at a CAGR of 4.9% during the forecast period.

Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market

Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market

Attention-Deficit Hyperactivity Disorder (ADHD) treatment refers to a range of medical, psychological, and educational interventions aimed at managing symptoms such as inattention, hyperactivity, and impulsivity. Common approaches include pharmacological therapies like stimulant medications (e.g., methylphenidate, amphetamines), non-stimulant drugs (e.g., atomoxetine), as well as behavioral therapy, cognitive behavioral therapy (CBT), and parental or educational support. ADHD treatment is often tailored to the individual’s age, symptom severity, and personal needs, with the goal of improving daily functioning, academic performance, and overall quality of life.
The ADHD treatment market is growing steadily due to rising awareness and diagnosis rates of the disorder, especially among children and young adults. Increased recognition of ADHD symptoms by parents, educators, and healthcare professionals has led to earlier intervention and expanded treatment coverage. Government health initiatives and the integration of behavioral health into primary care are also improving access to diagnosis and therapy. The demand for multimodal treatment approaches—combining medication, behavioral therapy, and counseling—is further boosting market potential. Pharmaceutical advancements have led to the development of long-acting stimulants, non-stimulant drugs, and personalized medicine strategies, offering more treatment choices with fewer side effects. Moreover, increasing mental health advocacy and reduced stigma are encouraging more individuals to seek professional help, which, combined with telemedicine platforms and digital therapeutics, is making ADHD treatment more accessible than ever.
Despite growth, the ADHD treatment market faces several challenges. Misdiagnosis remains a concern, especially in cases where ADHD symptoms overlap with other mental health conditions like anxiety, depression, or autism spectrum disorder. Access to qualified mental health professionals is still limited in many regions, leading to disparities in treatment availability. Stimulant medications, although effective, raise concerns around dependency, side effects, and misuse, especially among teenagers and young adults. Regulatory hurdles and strict prescription controls in some countries also limit treatment flexibility. In addition, high treatment costs—especially for long-term therapy and branded drugs—can deter patients from completing full treatment cycles. Social stigma, particularly in less developed regions, continues to hinder individuals from seeking or adhering to ADHD therapy, affecting market penetration and long-term treatment success.
This report aims to provide a comprehensive presentation of the global market for Attention Deficit Hyperactivity Disorder (ADHD) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Attention Deficit Hyperactivity Disorder (ADHD) Treatment.
The Attention Deficit Hyperactivity Disorder (ADHD) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Attention Deficit Hyperactivity Disorder (ADHD) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Attention Deficit Hyperactivity Disorder (ADHD) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Report

Report Metric Details
Report Name Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market
Accounted market size in year US$ 13245 million
Forecasted market size in 2031 US$ 18640 million
CAGR 4.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Stimulant
  • Non-Stimulant
Segment by Application
  • Hospital Pharmacy
  • Retail Pharmacy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma, Zhengdafenhai, Highland Therapeutics, Jubilant Life Sciences, Medice Arzneimittel Putter, Lannett
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Attention Deficit Hyperactivity Disorder (ADHD) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market growing?

Ans: The Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market witnessing a CAGR of 4.9% during the forecast period 2025-2031.

What is the Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market size in 2031?

Ans: The Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market size in 2031 will be US$ 18640 million.

Who are the main players in the Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market report?

Ans: The main players in the Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market are Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma, Zhengdafenhai, Highland Therapeutics, Jubilant Life Sciences, Medice Arzneimittel Putter, Lannett

What are the Application segmentation covered in the Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market report?

Ans: The Applications covered in the Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market report are Hospital Pharmacy, Retail Pharmacy

What are the Type segmentation covered in the Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market report?

Ans: The Types covered in the Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market report are Stimulant, Non-Stimulant

Recommended Reports

Disorder Treatment Markets

Neuropsychiatric Therapies

CNS & Learning Disorders

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stimulant
1.2.3 Non-Stimulant
1.3 Market by Application
1.3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Perspective (2020-2031)
2.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Growth Trends by Region
2.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Attention Deficit Hyperactivity Disorder (ADHD) Treatment Historic Market Size by Region (2020-2025)
2.2.3 Attention Deficit Hyperactivity Disorder (ADHD) Treatment Forecasted Market Size by Region (2026-2031)
2.3 Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Dynamics
2.3.1 Attention Deficit Hyperactivity Disorder (ADHD) Treatment Industry Trends
2.3.2 Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Drivers
2.3.3 Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Challenges
2.3.4 Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Treatment Players by Revenue
3.1.1 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Treatment Players by Revenue (2020-2025)
3.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Top Attention Deficit Hyperactivity Disorder (ADHD) Treatment Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue
3.4 Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Concentration Ratio
3.4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue in 2024
3.5 Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD) Treatment Head office and Area Served
3.6 Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD) Treatment, Product and Application
3.7 Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD) Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Attention Deficit Hyperactivity Disorder (ADHD) Treatment Breakdown Data by Type
4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Historic Market Size by Type (2020-2025)
4.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Forecasted Market Size by Type (2026-2031)
5 Attention Deficit Hyperactivity Disorder (ADHD) Treatment Breakdown Data by Application
5.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Historic Market Size by Application (2020-2025)
5.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size (2020-2031)
6.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Country (2020-2025)
6.4 North America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size (2020-2031)
7.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Country (2020-2025)
7.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size (2020-2031)
8.2 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size (2020-2031)
9.2 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Country (2020-2025)
9.4 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size (2020-2031)
10.2 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Treatment Introduction
11.1.4 Takeda Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
11.1.5 Takeda Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Treatment Introduction
11.2.4 Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Treatment Introduction
11.3.4 Novartis Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Treatment Introduction
11.4.4 Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
11.4.5 Eli Lilly Recent Development
11.5 Tris Pharma
11.5.1 Tris Pharma Company Details
11.5.2 Tris Pharma Business Overview
11.5.3 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Treatment Introduction
11.5.4 Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
11.5.5 Tris Pharma Recent Development
11.6 Neos Therapeutics
11.6.1 Neos Therapeutics Company Details
11.6.2 Neos Therapeutics Business Overview
11.6.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Treatment Introduction
11.6.4 Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
11.6.5 Neos Therapeutics Recent Development
11.7 Mallinckrodt
11.7.1 Mallinckrodt Company Details
11.7.2 Mallinckrodt Business Overview
11.7.3 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Treatment Introduction
11.7.4 Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
11.7.5 Mallinckrodt Recent Development
11.8 Amneal Pharmaceuticals
11.8.1 Amneal Pharmaceuticals Company Details
11.8.2 Amneal Pharmaceuticals Business Overview
11.8.3 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Treatment Introduction
11.8.4 Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
11.8.5 Amneal Pharmaceuticals Recent Development
11.9 Noven Pharmaceuticals
11.9.1 Noven Pharmaceuticals Company Details
11.9.2 Noven Pharmaceuticals Business Overview
11.9.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Treatment Introduction
11.9.4 Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
11.9.5 Noven Pharmaceuticals Recent Development
11.10 Purdue Parma
11.10.1 Purdue Parma Company Details
11.10.2 Purdue Parma Business Overview
11.10.3 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Treatment Introduction
11.10.4 Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
11.10.5 Purdue Parma Recent Development
11.11 Zhengdafenhai
11.11.1 Zhengdafenhai Company Details
11.11.2 Zhengdafenhai Business Overview
11.11.3 Zhengdafenhai Attention Deficit Hyperactivity Disorder (ADHD) Treatment Introduction
11.11.4 Zhengdafenhai Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
11.11.5 Zhengdafenhai Recent Development
11.12 Highland Therapeutics
11.12.1 Highland Therapeutics Company Details
11.12.2 Highland Therapeutics Business Overview
11.12.3 Highland Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Treatment Introduction
11.12.4 Highland Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
11.12.5 Highland Therapeutics Recent Development
11.13 Jubilant Life Sciences
11.13.1 Jubilant Life Sciences Company Details
11.13.2 Jubilant Life Sciences Business Overview
11.13.3 Jubilant Life Sciences Attention Deficit Hyperactivity Disorder (ADHD) Treatment Introduction
11.13.4 Jubilant Life Sciences Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
11.13.5 Jubilant Life Sciences Recent Development
11.14 Medice Arzneimittel Putter
11.14.1 Medice Arzneimittel Putter Company Details
11.14.2 Medice Arzneimittel Putter Business Overview
11.14.3 Medice Arzneimittel Putter Attention Deficit Hyperactivity Disorder (ADHD) Treatment Introduction
11.14.4 Medice Arzneimittel Putter Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
11.14.5 Medice Arzneimittel Putter Recent Development
11.15 Lannett
11.15.1 Lannett Company Details
11.15.2 Lannett Business Overview
11.15.3 Lannett Attention Deficit Hyperactivity Disorder (ADHD) Treatment Introduction
11.15.4 Lannett Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
11.15.5 Lannett Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Novartis
Takeda
Johnson & Johnson
Eli Lilly
Tris Pharma
NEOS Therapeutics
Mallinckrodt plc
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
Zhengdafenhai
Highland Therapeutics
Jubilant Life Sciences
Medice Arzneimittel Putter
Lannett
List of Tables
 Table 1. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Stimulant
 Table 3. Key Players of Non-Stimulant
 Table 4. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Share by Region (2020-2025)
 Table 8. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Share by Region (2026-2031)
 Table 10. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Trends
 Table 11. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Drivers
 Table 12. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Challenges
 Table 13. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Restraints
 Table 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Share by Players (2020-2025)
 Table 16. Global Top Attention Deficit Hyperactivity Disorder (ADHD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment as of 2024)
 Table 17. Ranking of Global Top Attention Deficit Hyperactivity Disorder (ADHD) Treatment Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD) Treatment, Headquarters and Area Served
 Table 20. Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD) Treatment, Product and Application
 Table 21. Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD) Treatment, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Type (2020-2025)
 Table 25. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Type (2026-2031)
 Table 27. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Application (2020-2025)
 Table 29. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue Market Share by Application (2026-2031)
 Table 31. North America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Takeda Company Details
 Table 47. Takeda Business Overview
 Table 48. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product
 Table 49. Takeda Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025) & (US$ Million)
 Table 50. Takeda Recent Development
 Table 51. Johnson & Johnson Company Details
 Table 52. Johnson & Johnson Business Overview
 Table 53. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product
 Table 54. Johnson & Johnson Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025) & (US$ Million)
 Table 55. Johnson & Johnson Recent Development
 Table 56. Novartis Company Details
 Table 57. Novartis Business Overview
 Table 58. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product
 Table 59. Novartis Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025) & (US$ Million)
 Table 60. Novartis Recent Development
 Table 61. Eli Lilly Company Details
 Table 62. Eli Lilly Business Overview
 Table 63. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product
 Table 64. Eli Lilly Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025) & (US$ Million)
 Table 65. Eli Lilly Recent Development
 Table 66. Tris Pharma Company Details
 Table 67. Tris Pharma Business Overview
 Table 68. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product
 Table 69. Tris Pharma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025) & (US$ Million)
 Table 70. Tris Pharma Recent Development
 Table 71. Neos Therapeutics Company Details
 Table 72. Neos Therapeutics Business Overview
 Table 73. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product
 Table 74. Neos Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025) & (US$ Million)
 Table 75. Neos Therapeutics Recent Development
 Table 76. Mallinckrodt Company Details
 Table 77. Mallinckrodt Business Overview
 Table 78. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product
 Table 79. Mallinckrodt Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025) & (US$ Million)
 Table 80. Mallinckrodt Recent Development
 Table 81. Amneal Pharmaceuticals Company Details
 Table 82. Amneal Pharmaceuticals Business Overview
 Table 83. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product
 Table 84. Amneal Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025) & (US$ Million)
 Table 85. Amneal Pharmaceuticals Recent Development
 Table 86. Noven Pharmaceuticals Company Details
 Table 87. Noven Pharmaceuticals Business Overview
 Table 88. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product
 Table 89. Noven Pharmaceuticals Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025) & (US$ Million)
 Table 90. Noven Pharmaceuticals Recent Development
 Table 91. Purdue Parma Company Details
 Table 92. Purdue Parma Business Overview
 Table 93. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product
 Table 94. Purdue Parma Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025) & (US$ Million)
 Table 95. Purdue Parma Recent Development
 Table 96. Zhengdafenhai Company Details
 Table 97. Zhengdafenhai Business Overview
 Table 98. Zhengdafenhai Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product
 Table 99. Zhengdafenhai Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025) & (US$ Million)
 Table 100. Zhengdafenhai Recent Development
 Table 101. Highland Therapeutics Company Details
 Table 102. Highland Therapeutics Business Overview
 Table 103. Highland Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product
 Table 104. Highland Therapeutics Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025) & (US$ Million)
 Table 105. Highland Therapeutics Recent Development
 Table 106. Jubilant Life Sciences Company Details
 Table 107. Jubilant Life Sciences Business Overview
 Table 108. Jubilant Life Sciences Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product
 Table 109. Jubilant Life Sciences Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025) & (US$ Million)
 Table 110. Jubilant Life Sciences Recent Development
 Table 111. Medice Arzneimittel Putter Company Details
 Table 112. Medice Arzneimittel Putter Business Overview
 Table 113. Medice Arzneimittel Putter Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product
 Table 114. Medice Arzneimittel Putter Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025) & (US$ Million)
 Table 115. Medice Arzneimittel Putter Recent Development
 Table 116. Lannett Company Details
 Table 117. Lannett Business Overview
 Table 118. Lannett Attention Deficit Hyperactivity Disorder (ADHD) Treatment Product
 Table 119. Lannett Revenue in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025) & (US$ Million)
 Table 120. Lannett Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Picture
 Figure 2. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Stimulant Features
 Figure 5. Non-Stimulant Features
 Figure 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Pharmacy Case Studies
 Figure 9. Retail Pharmacy Case Studies
 Figure 10. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Report Years Considered
 Figure 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Share by Region: 2024 VS 2031
 Figure 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Share by Players in 2024
 Figure 15. Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 16. The Top 10 and 5 Players Market Share by Attention Deficit Hyperactivity Disorder (ADHD) Treatment Revenue in 2024
 Figure 17. North America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Share by Country (2020-2031)
 Figure 19. United States Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Share by Country (2020-2031)
 Figure 23. Germany Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Ireland Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Share by Region (2020-2031)
 Figure 31. China Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia & New Zealand Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Share by Country (2020-2031)
 Figure 39. Mexico Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Share by Country (2020-2031)
 Figure 43. Israel Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Takeda Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
 Figure 47. Johnson & Johnson Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
 Figure 48. Novartis Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
 Figure 49. Eli Lilly Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
 Figure 50. Tris Pharma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
 Figure 51. Neos Therapeutics Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
 Figure 52. Mallinckrodt Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
 Figure 53. Amneal Pharmaceuticals Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
 Figure 54. Noven Pharmaceuticals Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
 Figure 55. Purdue Parma Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
 Figure 56. Zhengdafenhai Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
 Figure 57. Highland Therapeutics Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
 Figure 58. Jubilant Life Sciences Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
 Figure 59. Medice Arzneimittel Putter Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
 Figure 60. Lannett Revenue Growth Rate in Attention Deficit Hyperactivity Disorder (ADHD) Treatment Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Attention Deficit Hyperactivity Disorder Treatment Market Research Report 2024
ADHD Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Attention Deficit Hyperactivity Disorder ADHD Medications Market Research Report 2024
Global ADHD Medication Market Research Report 2025
Global Pediatric ADHD Drugs Market Research Report 2025
Global Attention Deficit Hyperactivity Disorder ADHD Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
ADHD Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Attention Deficit Hyperactivity Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global ADHD Test Online Market Research Report 2025
Global Attention Deficit Hyperactivity Syndrome Treatment Market Research Report 2025
Global Attention deficit Hyperactivity Disorder ADHD Therapeutics Market Research Report 2024
Global ADHD Medications Market Insights Forecast to 2030
Global Children Attention Deficit and Hyperactivity Disorder Market Research Report 2025
Global Attention Deficit and Hyperactivity Disorder Market Research Report 2025
Global Adult Attention Deficit and Hyperactivity Disorder Market Research Report 2025
Global ADHD Apps Market Research Report 2024
Methylphenidate Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Children ADHD Treatment Market Research Report 2024
Global ADHD Drug Treatment Market Research Report 2024
Learning Disabilities Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13Z8760
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Intracranial Pressure (ICP) Monitoring Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37L4006
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Brain Disease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12P6151
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3X6389
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions